Prolong Pharmaceuticals, Inc.
- UEI
- KMZXXHJC8MQ7
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Expired
Company facts
- Entity structure
- Other
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| TAS::75 4554::TAS biomedical (basic) | National Heart Lung and Blood Institute | $798,165 | |
| Development of peg hemoglobin blood substitute to treat hemorrhagic shock | National Institutes of Health | $1,014,678 | |
| Biomedical (applied/exploratory) | National Heart Lung and Blood Institute | $101,339 |
Quick answers
What is Prolong Pharmaceuticals, Inc.'s UEI?
Prolong Pharmaceuticals, Inc.'s Unique Entity ID (UEI) in SAM.gov is KMZXXHJC8MQ7.
Is Prolong Pharmaceuticals, Inc. registered in SAM.gov?
Prolong Pharmaceuticals, Inc.'s SAM.gov registration expired on June 1, 2009.
What is Prolong Pharmaceuticals, Inc.'s most recent federal award?
Prolong Pharmaceuticals, Inc.'s most recent federal contract award is TAS::75 4554::TAS biomedical (basic) (HHSN268200900038C), from National Heart Lung and Blood Institute, on June 1, 2009.
On GovTribe
See Prolong Pharmaceuticals, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors